Objective: Our goal was to test the recombinant human type II collagen (rhCII) material as a gel-like scaffold for chondrocytes in a nude mouse model in vivo. Design: Isolated bovine chondrocytes (6 Â 10 6 ) were seeded into rhCII gels (rhCII-cell) and injected subcutaneously into the backs of nude mice. For comparison, chondrocytes (6 Â 10 6 ) in culture medium (Med-cell) and cell-free rhCII gels (rhCII-gel) were similarly injected (n ¼ 24 animals, total of three injections/animal). After 6 weeks, the tissue constructs were harvested and analyzed. Results: Chondrocytes with or without rhCII-gel produced white resilient tissue, which in histological sections had chondrocytes in lacunae-like structures. Extracellular matrix stained heavily with toluidine blue stain and had strongly positive collagen type II immunostaining. The tissue did not show any evidence of vascular invasion or mineralization. The cell-free rhCII-gel constructs showed no signs of cartilage tissue formation. Cartilage tissue produced by Med-cell was thin and macroscopically uneven, while the rhCII-cell construct was smooth and rounded piece of neotissue. RhCII-cell constructs were statistically thicker than Med-cell ones. However, no statistical differences were found between the groups in terms of glycosaminoglycan (GAG) content or biomechanical properties. Conclusions: These results show that rhCII-gel provides good expansion and mechanical support for the formation of cartilage neotissue. RhCII material may allow favorable conditions in the repair of chondral lesions.
Introduction
Lesions in articular cartilage can cause severe pain, and they often lead to osteoarthritis (OA) when left untreated 1 . Accordingly, a number of methods have been developed to repair cartilage defects. These include microfracture surgery 2 , or transplantation of osteochondral plugs 3 . Although these methods have been used for small cartilage lesions with encouraging clinical results, they may cause significant associated morbidity or fibrous type of repair tissue, especially when large defects have been treated. Autologous chondrocyte transplantation (ACT) is a cell-based surgical method where isolated chondrocytes are transferred into the cartilage defect and covered with a periosteal flap 4 .
Novel techniques for cartilage repair aim to take the advantage of bioresorbable scaffold materials in combination with autologous chondrocytes 5, 6 . A cell-friendly, biodegradable, and simultaneously mechanically stiff, three-dimensional material with cell growth enhancing properties would be an optimal scaffold for chondrocytes 7 . This would improve the filling of the lesion site, and help the attachment of the repair tissue to the adjacent tissue. Currently, a large variety of natural and synthetic polymers with different compositions are under investigation, and also clinically used as scaffolds for chondrocytes 8e11 . However, convincing long-term clinical results from these new materials are still lacking and further studies are needed to assure the reliability and predictability of the materials to produce normal and healthy repair tissue 7 . As collagen is the major matrix component in the articular cartilage, it is considered to be a favorable material for cartilage tissue engineering. It has been reported that chondrocytes cultivated in type I collagen display a fibroblastic morphology, whereas cells in type II collagen retain their chondrocytic features and high biosynthetic activity 12 . However, due to its better availability, type I collagen has been often used in different modifications. Soft scaffolds with the collagens in a gel-like formula have also been under investigation 13e16 . Although it is obvious that the mechanical properties of soft gels are not comparable to stiffer materials, or native articular cartilage, the soft formula offers several desirable qualities, such as the flexible composition of the gels, a good flow of nutrients and sufficient space for cell proliferation and matrix production. The use of gels also enables an injectable delivery of cells and biomaterial 17 .
Immune-deficient nude mice have been used for various purposes in cartilage research. They were first used when chondrocytes from rabbits and dogs were injected subcutaneously 18 . Since then, nude mouse animals have become a commonly used model for designing matrices for cartilage reconstruction 19, 20 , e.g., to test in vivo chondrogenic cell differentiation and cartilage formation 21, 22 . Injectable chondrocyte suspension in fibrin gel polymer formed newly synthesized cartilage, i.e., neocartilage when injected subcutaneously, while fibrin glue alone produced no cartilage 23 . The same technique was used to compare how transforming growth factor-b 1 transfection affects human chondrocytes 24 . A nude mouse model has also been used to test the chondrogenic differentiation of mesenchymal stem cells 25, 26 .
The aim of our study was to use the nude mouse model to investigate a new recombinant human (rh) type II (rhCII) collagen biomaterial. Preliminary studies were done with recombinant collagens types I and III in vitro in comparison with the type II. The use of genetically modified microorganisms offers an effective way of producing safe and non-animal-derived materials for tissue engineering. Our previous results in vitro indicated that rhCII material is a feasible scaffold for chondrocytes 27 .
Methods

rh collagens
The rh collagens (types I, II and III) solubilized in HCl were provided by Fibrogen Europe (Helsinki, Finland). Collagen solutions were produced in yeast (Pichia pastoris) by recombinant technology, and then purified for further use. Recombinant strains of P. pastoris have been shown to synthesize properly hydroxylated triple helical recombinant collagen and, when coexpressed with recombinant prolyl hydroxylase, to produce collagen with a thermal stability similar to native collagens 28 .
Preliminary study in vitro with type I, II and III rh collagens
A preliminary study was conducted in vitro before nude mouse experiments to choose the most suitable collagen for further experiments [ Fig. 1(A, DeF) ]. Chondrocyte isolation, gel preparation, 4-week cultivation, and histological analyses were performed as described previously 27 . Based on histological evaluation, rhCII was selected for further studies in a nude mouse model in vivo.
Chondrocyte isolation
Articular cartilage was harvested from patellofemoral grooves of 18-month-old bovines (Atria abattoir, Kuopio, Finland). Chondrocytes were isolated from the cartilage slices in a two-step isolation protocol performed at 37 C and 5% CO 2 day, the cells were washed with phosphate-buffered saline (PBS) and suspended in DMEM into concentration of 1 Â10 7 cells/ml of medium. Cellular isolation was performed similarly four times from four different animals. After isolation, the viability of the cells was examined using two fluorescent probes, propidium iodide and fluorescein diacetate 29 .
Gel preparation and subcutaneous injections
Gels were made individually for each injection to guarantee similar volume in all samples. rhCII solution (600 ml) was combined with six million freshly isolated chondrocytes in growth medium (600 ml) in an Eppendorf tube. The mixture was allowed to gel in 37 C for 1 h. After gelling, the excessive liquid was removed with centrifugation. At the same time, rhCII gels without cells were made by combining rhCII solution (600 ml) and growth medium (600 ml). After removal of liquid, the volume used for injections was 400 ml/injection. For the scaffold-free controls, six million cells in growth medium were centrifuged to the same volume (400 ml). Before injection, the viability of the chondrocytes in the gels was tested as previously described 29 from extra gels made for this purpose. Experiments were carried on when cell viability was greater than 90%.
Nude mice were anaesthetized with 2e4% isoflurane (1-chloro-2,2,2-trifluoroethyl difluoromethyl ether, Isofluran Baxter, Baxter, Lessines, Belgium) before injection. Each mouse (n ¼ 24) was treated with three subcutaneous injections [ Fig. 2 (A)]: (1) cell-free rhCII gels (rhCII-gel); (2) bovine chondrocytes in rhCII-gel (rhCIIcell); and (3) bovine chondrocytes in growth medium (Med-cell). The injection sites were located in the back of the mice, laterally to the median plane of the animal in a triangular pattern [ Fig. 2(A) ]. No major scar formation or skin abnormalities were detected in the injection sites, and the animals behaved normally. After 6 weeks, the animals were euthanized with CO 2 , and the constructs and blood samples were collected for further analyses. The Institutional Animal Care and Use Committee of the University of Kuopio and the Provincial Government approved these animal experiments. Specimens (24 in each group) were collected from these triplicate injections and divided into further analyses. The total number of individual specimens was 7e12 in the analyses. Samples from rhCII-gel injections could not be used for further analyses, since no tissue formation was observed in the implantation sites.
Blood samples
Blood samples were collected from the mice at the time of euthanization. The values of leukocytes, erythrocytes, hemoglobin and thrombocytes were analyzed with an automated hematology analyzer (Cell Dyn 3500R, Abbott Laboratories, Abbott Park, IL), which has been shown to be a reliable and accurate instrument for murine blood analysis 30 . Blood of the animals injected with rhCII (n ¼ 12) was compared to that of the non-injected control animals of the same age (n ¼ 10).
Histological analyses
Formaldehyde-fixed constructs (n ¼ 12 for Med-cell and rhCIIcell) were embedded in Tissue-Tek III embedding wax (Sakura Finetek Europe, Zoeterwoude, Holland) and cut into 5-mm thick sections. Proteoglycans were stained with toluidine blue or safranin O, and bone with Masson's trichrome staining. Immunohistochemical staining was performed with anti-type II collagen mouse monoclonal antibody E8 31 , which recognizes bovine and murine type II collagens 32 . Type X collagen was immunostained with mouse monoclonal antibody X53 33 To analyze cellularity of the rhCII-cell and Med-cell constructs the sections were stained with hematoxylin, the mounted glasses were photographed, and the number of nuclei/mm 2 was counted with ImageJ 1.36b software (National Institute of Health, USA).
Enhanced polarized light microscopy
The specimens (n ¼ 12 for both Med-cell and rhCII-cell) were fixed in neutral phosphate-buffered 10% formalin, and prepared for the polarized light microscopic analysis as previously described 36 . Sections (5-mm thick) from the middle part of the sample were cut, dewaxed in xylene, and rehydrated. Tissue glycosaminoglycans (GAGs) were digested with testicular hyaluronidase. The sections were left unstained, embedded in DPX mounting medium (Difco, East Molesey, UK), and examined with a computerized Leitz-Ortholux POL microscope using 6.23 mm spatial resolution. The degree of parallelism of the collagen network, i.e., the parallelism index, and the absolute construct area were determined 37 .
Fourier-transformed infrared imaging
The 5-mm thick sections were prepared similarly to those used for polarized light microscopy, and transferred to infrared-transparent ZnSe-windows. Fourier-transformed infrared imaging spectroscopy (FT-IRIS) was utilized to determine the amide absorbance of the sections as a measure of collagen content 38 . The nominal spatial resolution of Spectrum Spotlight FTIR imaging system (Perkin Elmer, Cambridge, UK) was set to 6.25 mm, corresponding to the pixel size in use. The absolute specimen reference area was measured from amide spectrograms (mm 2 ). Mean amide absorbance values (per mm 2 ) were calculated with IPLab software (BD Biosciences, Rockville, MD, USA).
Biochemical analyses
The constructs were divided into two sample sets, one for the quantitative analysis of proteoglycans and one for the structural proteoglycan analysis by agarose gel electrophoresis. For quantitative analysis, the wet weights of the samples (n ¼ 11 for both groups: Med-cell and rhCII-cell) were measured. The samples were freeze-dried and weighted before further processing with papain digestion 27 . The uronic acid contents of the digests were quantified from the ethanol-precipitated samples 39 . The uronic acid content was normalized by the wet weight of the sample. The other set of specimens was extracted with 4 M guanidinium HCl in (GueHCl) 50 mM sodium acetate, pH 5.8, supplemented with 10 mM disodium EDTA, 5 mM benzaminide HCl and 100 mM 6-aminohexanoic acid for 48 h. For agarose gel electrophoretic analysis of proteoglycan subpopulations, the samples were precipitated with 75% ethanol. The precipitated samples (1 mg of uronic acid) were dissolved in 7 ml of sample buffer (1% SDS in 40 mM Triseacetate and 1 mM sodium sulfate, pH 6.8), boiled for 5 min, and 7 ml of 60% sucrose and 0.05% bromphenol blue in sample buffer was added to the samples. The electrophoresis in 1.2% agarose was performed in 40 mM Triseacetate and 1 mM sodium sulfate, pH 6.8, for 3 h at 60e80 mA and 40 V. After electrophoresis, the gel was fixed for 2 h in methanol:acetic acid:water (50:7:43, v:v:v) mixture, and stained with 0.02% toluidine blue in 3% acetic acid for 4 h. Excessive stain was removed by 3% acetic acid, and the gel was scanned. Bovine articular cartilage (GueHCl and papain extracted), mouse skin (GueHCl extracted) and chondroitin sulfate C (Sigma) were treated similarly as positive and negative controls.
Mechanical testing
For analysis of the mechanical properties of the rhCII-cell (n ¼ 10) and Med-cell (n ¼ 7) constructs the samples were cut with a 3 mm biopsy punch (Kai Industries, Oyana, Gifu, Japan) prior to testing. The cutting was performed to minimize changes in the sample shapes. A material testing device was used to analyze dynamic and equilibrium (Young's) modulus and the thickness of the cylindrical samples 40 .
Statistical analysis
Statistical comparisons between the groups, i.e., rhCII-cell and Med-cell, were made using ManneWhitney U test (for the cellularity, uronic acid, dynamic thickness and Young's modulus). P-value < 0.05 was set as a limit for statistical significance for all tests.
Results
Preliminary study in vitro with rh type I, II and III collagens
The in vitro cultivated chondrocyte-seeded rhCII gels [ Fig. 1(A) ] showed increased immunostaining for collagen type II during the cultivation from day 0 [ Fig. 1(B) ] to day 28 [ Fig. 1(C) ]. Proteoglycan staining with safranin O 41 showed the highest intensity for rhCII gels [ Fig. 1(E) ] compared with rh type I [ Fig. 1(D) ] and rh type III [ Fig. 1(F) ] collagens. Since type II collagen is also the major component in the articular cartilage we continued the experiments with rhCII gels.
Blood samples
Analysis of blood samples was performed to detect possible adverse effects of the rhCII material in the mice. No differences were detected between the control animals and the mice with rhCII constructs placed under their skin in terms of leukocytes, erythrocytes, thrombocytes, hemoglobin, and hematocrit (Table I) .
Macroscopical appearance and properties
After 6 weeks of implantation in a nude mouse, the rhCII-gel without cells had mostly dissolved, and only a barely detectable thin layer of material remained at the location of injection [ Fig. 2  (B) ]. The chondrocytes within rhCII-cell produced a round to oval piece of whitish, translucent and resilient tissue [ Fig. 2(C) and (D) ]. The cells of Med-cell also formed a piece of white tissue, but the appearance was thin, uneven and rough [ Fig. 2(E) ]. No macroscopic signs of vascular invasion or abnormal growth of connective tissue were detected around the constructs. The thickness measurement using a mechanical testing device revealed that the rhCII-cell constructs were two times thicker than the flattened Med-cell constructs (Table II) . Because rhCII-gel formed no tissue, it was no further analyzed.
Histological analyses
The chondrogenic character of the tissue constructs was examined with toluidine blue stainings ( Fig. 3 ). After 6 weeks' cultivation in vivo, rhCII-cell produced tissue that was heavily stained with cationic dye toluidine blue [ Fig. 3(A) ], indicating the presence of abundant extracellular matrix proteoglycans. Chondrocytes had also formed lacunae-like structures [ Fig. 3(B) ]. The findings in Med-cell were similar, except that the constructs were more condensed than the rhCII-cell construct [ Fig. 3 
(C) and (D)].
Collagen type II immunostaining was strongly positive in both rhCII-cell [ Fig. 3(E) ] and Med-cell [ Fig. 3(F) ] constructs. The Medcell construct was surrounded by type II-negative connective tissue. Negative controls stained with normal murine serum showed no or only faint staining of the respective tissue sections The stainings for hypertrophic or mineralizing cartilage markers (type X collagen and ALP activity) showed negative results in rhCIIcell and Med-cell samples, while staining in the positive controls was observed [ Fig. 5(AeF) ]. Masson's trichrome staining indicated that the ectopic cartilage implants stained with blue, as did the normal bovine cartilage [ Fig. 5(GeI) ]. The cellularity analysis revealed no differences between the rhCII-cell gel and Med-cell constructs (Table II) .
Biochemical analyses
The dry weight of tissue constructs produced by the rhCII-cell and Med-cell were 1.10 AE 0.33 mg (n ¼ 11), and 1.36 AE 0.82 mg (n ¼ 11), respectively. On the basis of similar uronic acid concentrations no detectable differences in GAG content were evident between the groups (Table II) . Agarose gel electrophoretic analysis [ Fig. 6 (G)] revealed that in both construct groups the proteoglycans were primarily large proteoglycans with the mobility typical of aggrecan molecules, while the amount of small proteoglycans (relative mobility of approximately 0.85e0.90 in proportion to the bromphenol blue front) was low, consistent with previous literature 42, 43 . The mobility of bovine articular cartilage proteoglycans was similar to rhCII-cell and Med-cell. Chondroitin sulfate C and papain-digested cartilage had faster mobility than small proteoglycan population [ Fig. 6(G) ]. No proteoglycan bands were seen from the mouse skin sample extract (data not shown).
FT-IRIS analysis and polarized light microscopy
The content of collagen was estimated by FT-IRIS analysis. The mean amide absorbance per pixel (representing the collagen content) was 0.50 Â 10 À3 AE 0.27 Â 10 À3 units/mm 2 in the rhCII-cell group and 0.43 Â 10 À3 AE 0.13 Â 10 À3 units/mm 2 in the Med-cell group. The average area of constructs did not differ either between the two groups (3.04 Â 10 6 AE 1.61 Â10 6 mm 2 vs 2.73 Â 10 6 AE 1.28 Â 10 6 mm 2 ).
However, Med-cell constructs [ Fig. 6 (E)] appeared to have higher variation in the local collagen content than rhCII-cell ones [ Fig. 6(B) ]. This can be related to more heterogeneous structure of Med-cell shown by toluidine blue-stained sections from the same region [ Fig. 6 (D) vs Fig. 6(A) ]. Polarized light microscopy analysis was used to evaluate the arrangement of collagen network of the constructs. The parallelism index was 0.32 AE 0.07 (mean AE SD) in the Med-cell and The values of leukocytes, erythrocytes, hemoglobin, hematocrit and thrombocytes in blood were analyzed after 6 weeks of injection of rhCII-gel and chondrocytes under the skin of nude mouse (n ¼ 12). Control samples were taken from non-treated mice (n ¼ 10). Values indicate the mean and 95% confidence intervals (95% CIs) of the results (lower limit, upper limit). Values indicate the mean and 95% CIs (lower limit, upper limit) of the results. Statistically significant difference (*) was noticed in the thickness of the constructs. Immunostaining for type II collagen showed a strong signal in cell-seeded rhCII constructs (rhCI-cell), particularly around the chondrocytes, suggesting accumulation of collagen type II (E), while non-cartilaginous areas negative for type II collagen were visible in scaffold-free constructs (Med-cell) (F). Negative controls treated with BSA in rhCII (G) and scaffold-free (H) constructs are shown. The bar ¼ 50 mm (100Â magnifications). 0.37 AE 0.10 in the rhCII-cell group. The same result can be seen visually in polarized light microscopic images captured from Medcell [ Fig. 6(F) ] and rhCII-cell [ Fig. 6(C) ] constructs.
Mechanical testing
Mechanical testing of the constructs was performed to obtain the Young's modulus and the dynamic modulus of the constructs. Although the macroscopic appearance of the tissue was different between the rhCII-cell and Med-cell constructs, there were no significant differences in the Young's or dynamic modulus (Table II) . The mechanical stiffness did not fully reach that of bovine articular cartilage 44 , but was higher than that obtained with in vitro cultivation 29 .
Discussion
In the present study, we show that rhCII-gel with chondrocytes (rhCII-cell) formed a tissue with abundant presence of collagen and proteoglycans when grown for 6 weeks subcutaneously in the backs of nude mice. The tissue formed during the 6-week cultivation resembled hyaline cartilage macroscopically and microscopically, although some staining for type I collagen was also observed. Cartilage-looking tissue was produced also by chondrocytes alone (Med-cell). Theoretically it is possible that the murine cells may contribute to the formation of the neotissue. However, the absence of cartilage formation in the cell-free rhCII-gel suggests that murine cells do not have major role in the ectopic cartilage formation.
The major difference between the groups was the structure of the constructs. Without scaffold, the resulting tissue was more flattened, and appeared to contain several layers of tissue, in contrast to the smooth, oval and more regular appearance of the rhCII-cell constructs. It appeared that the absence of scaffold allowed chondrocytes to spread between the membranous structures under the skin. In rhCII-gel, notably a more uniform tissue growth developed. The rhCII-cell constructs were also significantly thicker than the Med-cell. The benefits of this cohesive feature will become useful in practice when better filling of defects is desired.
Isolated articular chondrocytes are often presumed to be at an appropriate maturation stage to proliferate and also to differentiate to some extent 45 . These properties are important in cartilage repair. In this study we decided to use primary bovine chondrocytes to provide the construct with an optimal cell source, although in clinical applications the cells are usually expanded. Chondrocyte hypertrophy and terminal differentiation are not desired, since they lead to ossification of the repair tissue. Here, the chondrocytes in both construct types (rhCII-cell and Med-cell) expressed chondrocytic phenotype, and both produced lacunae-like formations during the 6-week long growth period. A high content of extracellular matrix proteoglycans was also detected. There were no signs of hypertrophy in neither of the constructs. Similar findings were detected in a previous study 26 , where it was noticed that expanded articular chondrocytes did not hypertrophy in immunocompromized mice. However, when differentiated mesenchymal stem cell-derived pellets were grown scaffold-free in a mouse model, the constructs underwent hypertrophy, had vascular invasion and deposited minute ossicles in the model 26 . In a previous study, basic fibroblast growth factor was used to promote the formation of vasculature around the construct 46 . In our study cartilage formation was evident without addition of growth factors, similar to chondrocytes cultured on fibrous synthetic materials 47 .
The chondrocytes maintained their capacity to produce extracellular matrix during the cultivation, indicated by the intense toluidine blue staining in both construct types. The proteoglycan staining and the intense pericellular immunostaining for type II collagen make it likely that the implanted chondrocytes produced also type II collagen. In our previous data in vitro 27 we could notice an increase in the matrix production in the rhCII-cell constructs cultivated for 4 weeks in cell culture conditions. In the present analysis in vivo, a much higher level of staining of the matrix was detected in the histological specimens after 6 weeks in vivo. Also the mechanical stiffness was remarkably different in these studies. When the rhCII-cell constructs were cultivated in vitro, the specimens were getting harder during the cultivation time but never got stiff enough to be mechanically analyzed (unpublished data). However, in the in vivo nude mouse model we could gain comparatively good stiffness with only 6 weeks of cultivation. Consequently the mouse model offers a major improvement to the cultivation environment and properties.
There was no difference between rhCII-cell and Med-cell in terms of equilibrium and dynamic stiffness. Furthermore, the mechanical stiffness of the constructs did not reach the level of adult articular cartilage. It has been shown that the biomechanical properties of bovine articular cartilage change during a long period of maturation from fetal to calf to adult 48 . This process involves maturation and crosslinking of the collagen network; this large scale remodeling significantly affects the functional properties of the tissue 49 . Obviously, the present 6-week implantation period was too short for the maturation of the constructs. Naturally, the mechanical properties and other biological characteristics under the skin do not exactly resemble the conditions in a normal joint. Addition of crosslinking agents or stabilizers could have improved the stiffness of the gels, but these were not used due to their potential interference with the natural remodeling of the construct material.
The impaired organization of the implant was most evident in the polarized light microscopic analyses of the rhCII-cell and Medcell tissues. The polarization signal of both constructs differed markedly from the one obtained from the normal articular cartilage, indicating that the collagen fibers were not orientated as in native cartilage. The collagen content appeared rather similar in both implantation groups.
No signs of vascular invasion or increased vasculature were detected around the neotissue constructs, but apparently both rhCII-cell and Med-cell structures were able to receive sufficient nutrients and oxygen from the surrounding connective tissue, and the use of rhCII-gel did not weaken the survival of the cells. This is important, since it has been shown previously that a biomaterial, although otherwise promising, can be lethal to the cells if it does not allow even distribution of the cells, exchange of essential molecules, or if the decomposing particles are toxic 50 .
For clinical applications, it is advantageous to retain the implant shape during the regeneration progress. In this study, rhCII-cell constructs showed regular expansion and round shapes, demonstrating the growth potential of the neotissue, whereas the Med-cell constructs had a much more irregular and malformed appearance. It has been shown in vitro that the chondrocyteseeded type I collagen gels contract remarkably during cultivation 15 . This was revealed also in rhCII-seeded gels in vitro 27 . However, the contraction was not a particular problem in the nude mouse model.
In conclusion, the use of animal-component free rhCII-gel as a scaffold for chondrocytes promoted a better maintenance of neotissue construct shape, compared with the cells without a scaffold. The soft gel material without any synthetic or animalderived additives allows a safe and reproducible way of adding more structural competence to the implantation of chondrocytes. The results of this study indicate that the rhCII material might also be used for other applications, such as in a replacement procedure for nasal cartilages. By using external pre-shaped scaffolds, a desired three-dimensional structure to shape the forming neocartilage may be achieved. In summary, rhCII scaffold, with its structural properties, is potentially useful for cartilage tissue engineering. 
